Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Clinical Pathology|January 29, 2005
Imprinting, expression, and localisation of DLK1 in Wilms tumoursR Fukuzawa, R W Heathcott, I M Morison, et al.Journal of the American College of Cardiology|August 1, 1997
Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary studyM J Williams, I M Morison, J H Parker, et al.Human Molecular Genetics|December 1, 1993
Human insulin-like growth factor type I and type II receptors are not imprintedO Ogawa, L A McNoe, M R Eccles, et al.Nature Medicine|March 1, 1996
Somatic overgrowth associated with overexpression of insulin-like growth factor III M Morison, D M Becroft, T Taniguchi, et al.Oncogene|January 13, 2009
Canonical WNT signalling determines lineage specificity in Wilms tumourR Fukuzawa, M R Anaka, R J Weeks, et al.Oncogene|August 17, 1995
Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumourT Taniguchi, A E Schofield, J L Scarlett, et al.The New Zealand Medical Journal|January 7, 1998
Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosisM J Burt, J D Upton, I M Morison, et al.British Journal of Haematology|October 1, 1982
Standardization of prekallikrein activator (PKA): the 1st British reference preparation for PKAP J Kerry, A D Curtis, C J Paton, et al.The New Zealand Medical Journal|May 11, 2001
Dietary iron intakes and biochemical iron status of 15-49 year old women in New Zealand: is there a cause for concern?E L Ferguson, I M Morison, J M Faed, et al.The Journal of Pathology|May 20, 2008
Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changesR Fukuzawa, M R Anaka, R W Heathcott, et al.Pageof 3